March 24, 2020
KM Biologics and Takeda Pharmaceutical said on March 23 that they will terminate their sales partnership in Japan for Influenza HA Vaccine “KMB”, which is manufactured by KM Biologics, at the end of this month. No specific reasons of the...read more